Novartis
NVS
#54
Rank
โ‚ฌ207.59 B
Marketcap
104,63ย โ‚ฌ
Share price
0.88%
Change (1 day)
11.25%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2024 (TTM): โ‚ฌ48.05 Billion

According to Novartis's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.94 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ42.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ49.70 B17.76%
2023 โ‚ฌ42.20 B-9.03%
2022 โ‚ฌ46.39 B-0.63%
2021 โ‚ฌ46.69 B15.09%
2020 โ‚ฌ40.56 B-6.64%
2019 โ‚ฌ43.45 B3.85%
2018 โ‚ฌ41.84 B0.14%
2017 โ‚ฌ41.78 B-11.1%
2016 โ‚ฌ46.99 B1.99%
2015 โ‚ฌ46.08 B4.5%
2014 โ‚ฌ44.09 B9.23%
2013 โ‚ฌ40.37 B-7.22%
2012 โ‚ฌ43.51 B-4.82%
2011 โ‚ฌ45.72 B17.95%
2010 โ‚ฌ38.76 B23.13%
2009 โ‚ฌ31.48 B3.35%
2008 โ‚ฌ30.46 B14.74%
2007 โ‚ฌ26.54 B0.08%
2006 โ‚ฌ26.52 B-3.17%
2005 โ‚ฌ27.39 B31.56%
2004 โ‚ฌ20.82 B5.44%
2003 โ‚ฌ19.74 B-11.47%
2002 โ‚ฌ22.30 B1.22%
2001 โ‚ฌ22.04 B-0.26%
2000 โ‚ฌ22.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ58.56 B 22.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ55.72 B 16.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ82.33 B 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.45 B-7.27%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ37.31 B-22.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ15.33 B-68.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ44.77 B-6.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.20 B-20.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.12 B 4.55%๐Ÿ‡ฌ๐Ÿ‡ง UK